Sfoglia per Rivista
Two novel homozygous mutations in the fibrinogen genes identified in two Iranian afibrinogenemic patients
2006 L. Monaldini, S. Duga, R. Asselta, F. Peyvandi, M. Karimi, M. Malcovati, M.L. Tenchini
A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen
2013 F. Stufano, A.S. Lawrie, S. La Marca, P.E.C. Berbenni, L. Baronciani, F. Peyvandi
Ultrasonography of haemophilic arthropathy
2012 M. Perja, S. Riva, B. Grochowska, L. Mangiafico, D. Mago, A. Gringeri
Understanding FVIII/VWF complex : report from a symposium of XXIX WFH meeting 2010
2012 A. Gringeri, F.A. Ofosu, S. Grancha, J. Oldenburg, N.P. Ewing, A.B . Federici
Unresolved issues in prophylaxis
2002 S.A. Brown, L.M. Aledort, J. Astermark, E. Berntorp, M. van den Berg, V. Blanchette, S. Donfield, A. Gringeri, M. Hilgartner, R. Kulkarni, C. Leissinger, C. Negrier, R. Nuss, H. Petterson, P. Petrini, N. Poulios, W. Schramm, R. Table Group
The use of desmopressin in open-heart surgery
2008 M. Cattaneo
The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977–2007)
2008 A.B. Federici
Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders
2021 R. Kaczmarek, M. El Ekiaby, D.P. Hart, C. Hermans, M. Makris, D. Noone, B. O'Mahony, D. Page, F. Peyvandi, S.W. Pipe, T. Sannie, U. Schlenkrich, M.W. Skinner, A. Srivastava, A. Bok, G.F. Pierce
The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia
2024 P.A. Cortesi, C. Fornari, S. Conti, B. Pollio, E. Boccalandro, A. Buzzi, C. Carulli, A. Coppola, R. De Cristofaro, M.N.D. Di Minno, G. Dolan, E. Ferri Grazzi, A. Fornari, R. Gualtierotti, C. Hermans, V. Jiménez‐juste, G. Kenet, A. Lupi, C. Martinoli, M.F. Mansueto, G. Nicolò, A. Tagliaferri, A. Gringeri, A.C. Molinari, L.G. Mantovani, G. Castaman
von Willebrand disease : laboratory aspects of diagnosis and treatment
2004 E.J. Favaloro, D. Lillicrap, M.A. Lazzari, M.N. Cattaneo, C. Mazurier, A. Woods, S. Meschengieser, A. Blanco, A.C. Kempfer, A. Hubbard, A. Chang
von Willebrand disease in the 21st century: current approaches and new challenges
2009 P.M. Mannucci, A.B. Federici, A.H. James, C.M. Kessler
von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients
2016 M.T. Pagliari, L. Baronciani, F. Stufano, I. Garcia-Oya, G. Cozzi, F. Franchi, F. Peyvandi
von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? : a meeting report
2008 A.B. Federici, P.M. Mannucci, P. Marco
Von Willebrand's disease : a report from a meeting in the Åland islands
2012 E. Berntorp, I. Peake, U. Budde, M. Laffan, R. Montgomery, J. Windyga, A. Goodeve, P. Petrini, M. von Depka, W. Miesbach, D. Lillicrap, A.B. Federici, R. Lassila, G. White
von Willebrand's disease: clinical management
2006 A.B. Federici, G. Castaman, A. Thompson, E. Berntorp
VWF/FVIII concentrates in high-risk immunotolerance : the RESIST study
2007 A. Gringeri
Willebrand Disease
2012 F. Peyvandi
World Federation of Hemophilia Gene Therapy Registry
2020 B.A. Konkle, D. Coffin, G.F. Pierce, C. Clark, L. George, A. Iorio, J. Mahlangu, M. Naccache, B. O'Mahony, F. Peyvandi, S. Pipe, A. Quartel, E.K. Sawyer, M.W. Skinner, B. Tortella, C. Watson, I. Winburn
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile